UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

IMPACT OF SOCIOECONOMIC DISPARITIES ON THE 12-ITEM SHORT-FORM HEALTH SURVEY (SF-12) QUALITY OF LIFE INSTRUMENT AMONG OSTEOARTHRITIS PATIENTS

Value in health, 2016-05, Vol.19 (3), p.A237-A237

2016

Volltextzugriff (PDF)

Evaluation of Different Approaches for Confounding in Nonrandomised Observational Data: A Case-Study of Antipsychotics Treatment

Community mental health journal, 2014-08, Vol.50 (6), p.711-720

2014

Volltextzugriff (PDF)

Economic Impact of a Genomic Companion Diagnostic Test for Breast Cancer Patients in French Private Hospitals

Value in health, 2014-11, Vol.17 (7), p.A623-A623

2014

Volltextzugriff (PDF)

Future Impact of Dementia on the Caregiver in China

Value in health, 2014-11, Vol.17 (7), p.A769-A769

2014

Volltextzugriff (PDF)

Patient’s preferences for dry powder inhaler attributes in Asthma and Chronic Obstructive Pulmonary Disease: a discrete choice experiment

Value in health, 2015-05, Vol.18 (3), p.A47-A48

2015

Volltextzugriff (PDF)

Treatment Patterns and Health Care Costs in Patients with Schizophrenia Initiating with First- or Second-Generation Antipsychotic: Results from a Japanese Claims Database Analysis

Value in health, 2014-11, Vol.17 (7), p.A466-A466

2014

Volltextzugriff (PDF)

Treatment Patterns and Health Care Costs in Patients with Depression Treated with Antidepressant only or Combined with Benzodiazepine: Results From a Japanese Claims Database Analysis

Value in health, 2014-11, Vol.17 (7), p.A466-A466

2014

Volltextzugriff (PDF)

Identification of Dry Powder Inhaler Attributes, and their Relative Importance to Asthma and Chronic Obstructive Pulmonary Disease Patients, to Inform a Discrete Choice Experiment

Value in health, 2014-11, Vol.17 (7), p.A600-A600

2014

Volltextzugriff (PDF)

Social Contacts Reduce Negative Symptoms, Especially Emotional Withdrawal in Patients with Schizophrenia

Value in health, 2014-11, Vol.17 (7), p.A455-A455

2014

Volltextzugriff (PDF)

An economic evaluation of oxaliplatin for the adjuvant treatment of colon cancer in the United Kingdom (UK)

European journal of cancer (1990), 2007-07, Vol.43 (11), p.1687-1693

2007

Volltextzugriff (PDF)

Estimation of the effect of buprenorphine/naloxone dosing in medicaid opioid-dependent patients

Value in health, 2014-05, Vol.17 (3), p.A213-A213

2014

Volltextzugriff (PDF)

A studies-based private insurance budget impact analysis of buprenorphine / naloxone film and tablet formulations

Value in health, 2014-05, Vol.17 (3), p.A213-A213

2014

Volltextzugriff (PDF)

Medicaid population budget impact analysis of buprenorphine/naloxone film and tablet formulation

Value in health, 2014-05, Vol.17 (3), p.A212-A212

2014

Volltextzugriff (PDF)

Comparison of Health Care Resource use and Costs in Patients with Opioid Prescription Drug Dependence (Opd) Treated with Buprenorphine/Naloxone and Patients without Pharmacological Treatment: Retrospective Analysis of us Public Insurance Claims

Value in health, 2014-11, Vol.17 (7), p.A463-A464

2014

Volltextzugriff (PDF)

Analysis of ‘Revolving Door' Patients in Opioid Dependent Patients: the Impact of Treatment Discontinuation on Relapse Rates and Health Care Costs in us Public Health Insurance Claims

Value in health, 2014-11, Vol.17 (7), p.A456-A456

2014

Volltextzugriff (PDF)

Initiation of pharmacological treatment in Parkinson's disease in the UK: A Clinical Practice Research Datalink retrospective study

Journal of the neurological sciences, 2013-10, Vol.333, p.e88-e88

2013

Volltextzugriff (PDF)

The impact of treatment duration on relapse rates and health care costs among medicaid patients with opioid dependence treated with buprenorphine/naloxone

Value in health, 2014-05, Vol.17 (3), p.A215-A216

2014

Volltextzugriff (PDF)

Estimation of the effect of buprenorphine/naloxone dosing in privately insured opioid-dependent patients in the United States

Value in health, 2014-05, Vol.17 (3), p.A213-A213

2014

Volltextzugriff (PDF)

Cost-Effectiveness of Mirabegron Compared with Antimuscarinics for the Treatment of Patients with Overactive Bladder in the United Kingdom

Value in health, 2013-11, Vol.16 (7), p.A633-A634

2013

Volltextzugriff (PDF)

Cost-Effectiveness of Mirabegron Compared with Tolterodine ER 4mg for the Treatment of Patients with Overactive Bladder in the United Kingdom: Results from a Trial-Based Model

Value in health, 2013-11, Vol.16 (7), p.A633-A633

2013

Volltextzugriff (PDF)

A retrospective database study comparing treatment outcomes and cost associated with choice of fixed-dose inhaled corticosteroid/long-acting β2-agonists for asthma maintenance treatment in Germany

International journal of clinical practice (Esher), 2008-12, Vol.62 (12), p.1870-1879

2008

Volltextzugriff (PDF)

Analysis of health-related quality of life and costs based on a randomised clinical trial of escitalopram for relapse prevention in patients with generalised social anxiety disorder

International journal of clinical practice (Esher), 2008-11, Vol.62 (11), p.1693-1702

2008

Volltextzugriff (PDF)

PIN137 THE USE OF MULTI-YEAR AGE GROUPS IN VACCINATION MODELS BIAS THE RESULTS FOR VACCINATED INDIVIDUALS

Value in health, 2019-11, Vol.22, p.S661-S661

2019

Volltextzugriff (PDF)

PSY7 Cost-Minimisation Analysis of Recombinant Factor VIII FC Fusion Protein Versus Emicizumab for Haemophilia a Prophylaxis in Europe

Value in health, 2020-12, Vol.23, p.S743-S743

2020

Volltextzugriff (PDF)

A retrospective database study comparing treatment outcomes and cost associated with choice of fixed-dose inhaled corticosteroid/long-acting beta-agonists for asthma maintenance treatment in Germany

International journal of clinical practice (Esher), 2008-12, Vol.62 (12), p.1870-1879

2008

Volltextzugriff (PDF)

1 – 25 von 532

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(489)
Mit Volltextzugriff
(452)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

IMPACT OF SOCIOECONOMIC DISPARITIES ON THE 12-ITEM SHORT-FORM HEALTH SURVEY (SF-12) QUALITY OF LIFE INSTRUMENT AMONG OSTEOARTHRITIS PATIENTS

Evaluation of Different Approaches for Confounding in Nonrandomised Observational Data: A Case-Study of Antipsychotics Treatment

Economic Impact of a Genomic Companion Diagnostic Test for Breast Cancer Patients in French Private Hospitals

Future Impact of Dementia on the Caregiver in China

Patient’s preferences for dry powder inhaler attributes in Asthma and Chronic Obstructive Pulmonary Disease: a discrete choice experiment

Treatment Patterns and Health Care Costs in Patients with Schizophrenia Initiating with First- or Second-Generation Antipsychotic: Results from a Japanese Claims Database Analysis

Treatment Patterns and Health Care Costs in Patients with Depression Treated with Antidepressant only or Combined with Benzodiazepine: Results From a Japanese Claims Database Analysis

Identification of Dry Powder Inhaler Attributes, and their Relative Importance to Asthma and Chronic Obstructive Pulmonary Disease Patients, to Inform a Discrete Choice Experiment

Social Contacts Reduce Negative Symptoms, Especially Emotional Withdrawal in Patients with Schizophrenia

An economic evaluation of oxaliplatin for the adjuvant treatment of colon cancer in the United Kingdom (UK)

Estimation of the effect of buprenorphine/naloxone dosing in medicaid opioid-dependent patients

A studies-based private insurance budget impact analysis of buprenorphine / naloxone film and tablet formulations

Medicaid population budget impact analysis of buprenorphine/naloxone film and tablet formulation

Comparison of Health Care Resource use and Costs in Patients with Opioid Prescription Drug Dependence (Opd) Treated with Buprenorphine/Naloxone and Patients without Pharmacological Treatment: Retrospective Analysis of us Public Insurance Claims

Analysis of ‘Revolving Door' Patients in Opioid Dependent Patients: the Impact of Treatment Discontinuation on Relapse Rates and Health Care Costs in us Public Health Insurance Claims

Initiation of pharmacological treatment in Parkinson's disease in the UK: A Clinical Practice Research Datalink retrospective study

The impact of treatment duration on relapse rates and health care costs among medicaid patients with opioid dependence treated with buprenorphine/naloxone

Estimation of the effect of buprenorphine/naloxone dosing in privately insured opioid-dependent patients in the United States

Cost-Effectiveness of Mirabegron Compared with Antimuscarinics for the Treatment of Patients with Overactive Bladder in the United Kingdom

Cost-Effectiveness of Mirabegron Compared with Tolterodine ER 4mg for the Treatment of Patients with Overactive Bladder in the United Kingdom: Results from a Trial-Based Model

A retrospective database study comparing treatment outcomes and cost associated with choice of fixed-dose inhaled corticosteroid/long-acting β2-agonists for asthma maintenance treatment in Germany

Analysis of health-related quality of life and costs based on a randomised clinical trial of escitalopram for relapse prevention in patients with generalised social anxiety disorder

PIN137 THE USE OF MULTI-YEAR AGE GROUPS IN VACCINATION MODELS BIAS THE RESULTS FOR VACCINATED INDIVIDUALS

PSY7 Cost-Minimisation Analysis of Recombinant Factor VIII FC Fusion Protein Versus Emicizumab for Haemophilia a Prophylaxis in Europe

A retrospective database study comparing treatment outcomes and cost associated with choice of fixed-dose inhaled corticosteroid/long-acting beta-agonists for asthma maintenance treatment in Germany

Suchergebnisse filtern